Insider Transactions in Q3 2020 at Tracon Pharmaceuticals, Inc. (TCON)
Insider Transaction List (Q3 2020)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 24
2020
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
21,534
+0.7%
|
$86,136
$4.44 P/Share
|
Sep 23
2020
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
57,200
+1.99%
|
$228,800
$4.83 P/Share
|
Sep 11
2020
|
Ikarian Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
78,201
+3.49%
|
$234,603
$3.93 P/Share
|
Sep 09
2020
|
Ikarian Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
79,415
+3.67%
|
$238,245
$3.49 P/Share
|
Sep 09
2020
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
47,500
+1.83%
|
$142,500
$3.47 P/Share
|
Sep 08
2020
|
Ikarian Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
13,244
+0.66%
|
$26,488
$2.9 P/Share
|
Sep 04
2020
|
Ikarian Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
151,611
+7.07%
|
$303,222
$2.87 P/Share
|
Sep 04
2020
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
9,058
+0.38%
|
$18,116
$2.88 P/Share
|
Sep 02
2020
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
119,800
+4.3%
|
$239,600
$2.35 P/Share
|
Sep 01
2020
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
40,000
+1.54%
|
$80,000
$2.04 P/Share
|
Aug 31
2020
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
302,150
+7.18%
|
$302,150
$1.78 P/Share
|
Aug 28
2020
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
60,000
+22.22%
|
$60,000
$1.78 P/Share
|
Aug 27
2020
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
183,354
+26.25%
|
$183,354
$1.71 P/Share
|